RadNet (RDNT) Earnings: Q3 2026 Results

RadNet has reported a newer quarter since these figures. Everything below is for Q3 2026, the quarter ended September 30, 2026.

The quarter ended September 30, 2026 and RadNet published the results on November 8, 2026. Revenue and diluted EPS are shown against Q3 2025, the same quarter a year earlier, which takes seasonal swings out of the comparison. RadNet reports EPS two ways: GAAP, under the accounting rules every US filer follows, and Adjusted Diluted Earnings Per Share, which leaves out items the company considers outside its operating results. The release reconciles the two, and when they diverge, the reconciliation says why.

• Digital Health revenue is shown, as RadNet reports it, including sales to RadNet's own imaging centers; the elimination row (from the 10-Q segment note) removes those so the rows sum to consolidated revenue.
• RadNet restated its year-ago Adjusted Diluted EPS of $0.24 to add back losses on equipment disposal and Digital Health intangibles amortization, which it did not exclude when it first reported Q3 2025.
• Net income and EPS are attributable to RadNet common stockholders, after $15.0 million of net income attributable to noncontrolling interests.

Source: RadNet Q3 2026 results, November 8, 2026. Also in the Form 10-Q for the quarter ended September 30, 2026. Figures as reported; checked against the release on November 10, 2026.

How RadNet splits revenue in its own release, under its own labels, for Q3 2026 against Q3 2025. Indented lines are parts of the line above them.

• RadNet's Imaging Center revenue was $617 million in Q3 2026, up 21% from $508 million in Q3 2025, 97% of total revenue.
• RadNet's Digital Health (inclusive of intersegment revenue) revenue was $32.9 million in Q3 2026, up 33% from $24.8 million in Q3 2025, 5% of total revenue.

Segment lines are the figures writers cite most often, because they show where the growth in a quarter came from. Companies redraw their segments from time to time and restate the prior year to match, so a year-ago figure here can differ from the one printed a year ago. When that has happened, the note above says so.

From the earnings release

RadNet's ranges are a table in the release, by segment. Revised after Q3: Imaging Center total net revenue $2,385 million to $2,435 million, Adjusted EBITDA $350 million to $363 million and free cash flow $120 million to $130 million; Digital Health revenue $135 million to $145 million (unchanged). RadNet gives no EPS outlook.

In its Q3 2026 release, RadNet said:

“The Imaging Center segment has outperformed projections in each of the first three quarters of this year.”

“As a result, we are raising its guidance ranges for Revenue, Adjusted EBITDA (1) and Free Cash Flow (2).”

“In the Digital Health segment, we are raising the Adjusted EBITDA (1) guidance range as a result of effective expense management and faster-than-projected integration of acquired operations.”

Source: RadNet Q3 2026 release, Nov 8, 2026.

This is the company's own guidance as of Nov 8, 2026, quoted as given. Walnut does not make forecasts of its own. Analyst estimates for the coming quarters are on the RDNT forecast page.

Revenue and diluted EPS for the last 5 quarters. Each date links to that quarter's release.

Total service revenue and diluted EPS attributable to RadNet common stockholders, each as first reported in that quarter's release (RadNet reports in thousands; shown here in millions). RadNet dates its releases a day before filing them with the SEC; the report date is the release date.

We do not hold a confirmed date for RadNet's next report. Companies post the date on their investor relations site a few weeks ahead, usually with the time of the conference call.

Each quarter keeps its own page with the figures as reported, so a link to one stays pointed at the same numbers after the next report.

• Q3 2026 (this page), reported Nov 8, 2026

RadNet runs outpatient diagnostic imaging centers, 418 of them at the end of 2025, directly or through hospital and health system joint ventures, in states including California, New York, New Jersey, Maryland and Florida. The Imaging Center segment brought in $617.0 million of RadNet's $638.3 million total service revenue in Q3 2026, against $508.2 million a year earlier. (RadNet Form 10-K, 2025, Mar 2, 2026; RadNet Form 10-Q, Q3 2026, Nov 9, 2026; RadNet Q3 2026 release, Nov 8, 2026)

RadNet's revenue rose 22.1%. Its CEO attributed the growth to adding and filling capacity at existing centers, new center openings, the shift toward advanced imaging, tuck-in acquisitions, improved commercial reimbursement and the expansion of health system joint ventures. Aggregate advanced imaging volumes (MRI, CT and PET/CT) rose 19.9% and same-center advanced imaging volumes 8.9%. (RadNet Q3 2026 release, Nov 8, 2026)

Advanced imaging rose to 30.6% of RadNet's procedures from 28.2%, and MRI made up 38.6% of payments in the quarter, followed by mammography at 14.1% and ultrasound at 13.4%. By payor, commercial insurance was 56.4% of payments, Medicare 24.8% and capitation 4.9%. (RadNet Q3 2026 release, Nov 8, 2026)

RadNet's Digital Health segment, which sells AI and imaging software under the DeepHealth brand and includes the eRad subsidiary, had revenue of $32.9 million, up 32.6%, of which $11.7 million was sold to RadNet's own imaging centers and eliminated in consolidation. Its external revenue was $21.2 million. (RadNet Q3 2026 release, Nov 8, 2026; RadNet Form 10-Q, Q3 2026, Nov 9, 2026)

RadNet's GAAP diluted EPS was $0.05 in Q3 2026 against $0.07, even though consolidated net income rose to $19.2 million from $13.9 million, because $15.0 million was attributable to noncontrolling interests. Net income attributable to RadNet common stockholders was $4.2 million, against $5.4 million. (RadNet Q3 2026 release, Nov 8, 2026)

RadNet's Adjusted Diluted EPS was $0.30, against a restated $0.24. Adjusted earnings of $23.8 million add back, among other items, $8.3 million of non-cash change in contingent consideration, $7.3 million of Digital Health intangibles amortization, $5.6 million of non-capitalized DeepHealth research and development, a $5.4 million loss on equipment disposal and $2.8 million of legal settlements, and subtract a $7.5 million gain on contributing imaging centers into joint ventures. The adjustments are tax effected at 30.4%. (RadNet Q3 2026 release, Nov 8, 2026)

RadNet's diluted share count rose to 79.2 million from 77.4 million. Interest expense rose to $20.7 million from $17.4 million, and depreciation and amortization to $47.0 million from $39.8 million. (RadNet Q3 2026 release, Nov 8, 2026)

Diluted EPS divides net income by the weighted average number of shares outstanding in the quarter, plus the shares that options and other equity awards could add. Buybacks shrink that count and lift EPS for the same profit; share issuance and stock awards enlarge it.

RadNet gives full-year guidance by segment in its release, with no EPS outlook, and revised it for the third time this year. After Q3 it raised Imaging Center total net revenue to $2,385 million to $2,435 million, Adjusted EBITDA to $350 million to $363 million and free cash flow to $120 million to $130 million. Its original ranges were $2,325 million to $2,375 million and $335 million to $348 million. (RadNet Q3 2026 release, Nov 8, 2026)

RadNet kept Digital Health revenue guidance at $135 million to $145 million and raised Digital Health Adjusted EBITDA before non-capitalized research and development to $11 million to $13 million. The CEO also pointed to the pending acquisition of ONRAD. (RadNet Q3 2026 release, Nov 8, 2026)

A consensus figure is the average of the models published by the analysts who cover RadNet, collected by a data provider and revised up to the day of the report. A quarter that lands above it says how expectations were set as much as how the business did, and the share price on the day also reflects the guidance and the lines no consensus covers.

The consensus figures on this page are Yahoo Finance's, as pulled on the date shown. Each comes with the number of analysts behind it; the smaller that number, the more one revised estimate can move the average.

The figures below are the ones RadNet's own release and filings put weight on for Q3 2026, with the latest reported value for each.

What the quarter means for a holding is a separate question from what it reported. The case for and against owning RDNT is on is RDNT a buy or a sell?, what analysts expect next is on the RDNT forecast, and what the company does is on the RadNet (RDNT) stock page.

Every number on this page can be traced to a document RadNet published. Checking one takes a couple of minutes, and it is worth doing before you quote a figure anywhere.

• The results release is the document linked in the source line above. Companies publish it on their investor relations site at the moment results go out, and it carries the headline tables: revenue, operating income, net income and EPS for the quarter and the year-ago quarter.
• The same release is filed with the SEC as Exhibit 99.1 to a Form 8-K under Item 2.02, usually on the day of the report. The SEC copy does not change after the fact, which makes it the safer thing to link when you cite a number.
• The quarterly report (Form 10-Q) follows within a few weeks and carries the full financial statements, the segment note and management's discussion of what changed. The fourth quarter is covered by the annual report (Form 10-K) instead.
• Restated comparisons are flagged in the notes on this page. When a company redraws its segments or changes how it adjusts EPS, it restates the year-ago column, so the year-ago figure in a new release can differ from the one printed a year ago. This page always uses the comparison in the newer release, because that is the like-for-like one.

A walk-through of every line in a release, with what each one tells you, is in how to read an earnings report.